In the following interview, we had the opportunity to speak to Christian Weigand and Stefan Bartosch about their software development designed for conducting digital, decentralized clinical trials. Christian Weigand is...
Archive - November 2023
Yvonne Neß
Elisa BottUnderstanding the Why and How of Trustworthy AI
The rise of powerful, data-driven machine learning methods...
MIKAIA® University
MIKAIA® University is the central MIKAIA® learning portal. Here you can find various App Notes and Video Tutorials that describe typical MICAIA® workflows either from a technical or medical perspective. As we are...
Volker BrunsMIKAIA HER2 FISH App
About 20 % to 25 % of breast cancers depend on amplification and overexpression of the gene human epidermal growth factor receptor 2 (HER2). The HER2 overexpression status will initially be assessed by...
Nathalie FalkTherVacB Vaccine: MIKAIA Used in Preclinical Immunotoxicity Study
The TherVacB project, led by Helmholtz Zentrum München, received a five-year funding within the Horizon 2020 program. With TherVacB, a therapeutic vaccine to cure Hepatitis B, the project’s aim is to provide a...
